Jundishapur Journal of Microbiology

Published by: Kowsar

Synergistic Effects of Bismuth Thiols and Various Antibiotics Against Pseudomonas aeruginosa Biofilm

Maryam Varposhti 1 , Ahya Abdi Ali 1 , * and Parisa Mohammadi 1
Authors Information
1 Department of Biology, Faculty of Sciences, Alzahra University, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: March 01, 2014, 7 (3); e9142
  • Published Online: March 1, 2014
  • Article Type: Research Article
  • Received: November 17, 2012
  • Revised: April 24, 2013
  • Accepted: May 5, 2013
  • DOI: 10.5812/jjm.9142

To Cite: Varposhti M, Abdi Ali A, Mohammadi P. Synergistic Effects of Bismuth Thiols and Various Antibiotics Against Pseudomonas aeruginosa Biofilm, Jundishapur J Microbiol. 2014 ; 7(3):e9142. doi: 10.5812/jjm.9142.

Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. de Bentzmann S, Plesiat P. The Pseudomonas aeruginosa opportunistic pathogen and human infections. Environ Microbiol. 2011; 13(7): 1655-65[DOI][PubMed]
  • 2. Khan F, Shukla I, Rizvi M, Mansoor T, Sharma SC. Detection of biofilm formation in Staphylococcus aureus. Does it have a role in treatment of MRSA infections? Trends Med Res. 2011; 6(2)
  • 3. Mahami T, Adu-Gyamfi A, Owulah C. Comparative susceptibility of in vitro biofilm and planktonic cells of Staphylococcus aureus to antimicrobials. Afr J Microbiol Res. 2010; 4(12): 1209-14
  • 4. Van Eldere J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother. 2003; 51(2): 347-52[PubMed]
  • 5. Cornelis P. Pseudomonas aeruginosa: Genomics and Molecular Biology. 2008;
  • 6. Domenico P, Salo RJ, Novick SG, Schoch PE, Van Horn K, Cunha BA. Enhancement of bismuth antibacterial activity with lipophilic thiol chelators. Antimicrob Agents Chemother. 1997; 41(8): 1697-703[PubMed]
  • 7. Domenico P, O'Leary R, Cunha BA. Differential effects of bismuth and salicylate salts on the antibiotic susceptibility ofPseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 1992; 11(2): 170-5[DOI]
  • 8. Domenico P, Tomas JM, Merino S, Rubires X, Cunha BA. Surface antigen exposure by bismuth dimercaprol suppression of Klebsiella pneumoniae capsular polysaccharide. Infect Immun. 1999; 67(2): 664-9[PubMed]
  • 9. Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med. 1988; 85(3): 307-14[DOI]
  • 10. Abdi-Ali A, Mohammadi-Mehr M, Agha Alaei Y. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa. Int J Antimicrob Agents. 2006; 27(3): 196-200[DOI][PubMed]
  • 11. Bajaksouzian S, Visalli MA, Jacobs MR, Appelbaum PC. Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies. Antimicrob Agents Chemother. 1997; 41(5): 1073-6[PubMed]
  • 12. Tunney MM, Ramage G, Field TR, Moriarty TF, Storey DG. Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2004; 48(5): 1879-81[PubMed]
  • 13. Lewis RE, Diekema DJ, Messer SA, Pfaller MA, Klepser ME. Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J Antimicrob Chemother. 2002; 49(2): 345-51[PubMed]
  • 14. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003; 52(1): 1[DOI][PubMed]
  • 15. Shih PC, Huang CT. Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance. J Antimicrob Chemother. 2002; 49(2): 309-14[DOI]
  • 16. Acar JF. Antibiotic synergy and antagonism. Med Clin North Am. 2000; 84(6): 1391-406[DOI]
  • 17. Domenico P, Baldassarri L, Schoch PE, Kaehler K, Sasatsu M, Cunha BA. Activities of bismuth thiols against staphylococci and staphylococcal biofilms. Antimicrob Agents Chemother. 2001; 45(5): 1417-21[DOI][PubMed]
  • 18. Huang CT, Stewart PS. Reduction of polysaccharide production in Pseudomonas aeruginosa biofilms by bismuth dimercaprol (BisBAL) treatment. J Antimicrob Chemother. 1999; 44(5): 601-5[PubMed]
  • 19. Langley S, Beveridge TJ. Effect of O-side-chain-lipopolysaccharide chemistry on metal binding. Appl Environ Microbiol. 1999; 65(2): 489-98[PubMed]
  • 20. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002; 34(5): 634-40[DOI][PubMed]
  • 21. Ohge H, Furne JK, Springfield J, Sueda T, Madoff RD, Levitt MD. The effect of antibiotics and bismuth on fecal hydrogen sulfide and sulfate‐reducing bacteria in the rat. FEMS Microbiol let. 2003; 228(1): 137-42
  • 22. Nelson JM, Chiller TM, Powers JH, Angulo FJ. Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story. Clin Infect Dis. 2007; 44(7): 977-80[DOI][PubMed]
  • 23. Hooper DC. Mechanisms of fluoroquinolone resistance. Drug Resist Updat. 1999; 2(1): 38-55[DOI][PubMed]
  • 24. Shemesh M, Kolter R, Losick R. The biocide chlorine dioxide stimulates biofilm formation in Bacillus subtilis by activation of the histidine kinase KinC. J Bacteriol. 2010; 192(24): 6352-6[DOI][PubMed]
  • 25. Ryan RP, Dow JM. Diffusible signals and interspecies communication in bacteria. Microbiology. 2008; 154: 1845-58[DOI][PubMed]
  • 26. Baddour LM, Yu VL, Klugman KP, Feldman C, Ortqvist A, Rello J, et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med. 2004; 170(4): 440-4[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments